We are live on ! Find out more
FMI

F/M Investments Portfolio holdings

AUM $1.97B
1-Year Est. Return 30.33%
This Fund
S&P 500
This Quarter Est. Return
+18.64%
1 Year Est. Return
+30.33%
3 Year Est. Return
+101.46%
5 Year Est. Return
+144.03%
10 Year Est. Return
–
AUM
$137M
AUM Growth
-$3.13M
Cap. Flow
-$20.9M
Cap. Flow %
-15.32%
Top 10 Hldgs %
51.52%
Holding
108
New
28
Increased
8
Reduced
23
Closed
31

Top Buys

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$3.07M
2
PFE icon
Pfizer
PFE
+$2.88M
3
WOLF icon
Wolfspeed
WOLF
+$2.63M
4
OKTA icon
Okta
OKTA
+$2.61M
5
CSL icon
Carlisle Companies
CSL
+$2.42M

Top Sells

Rank Stock Value
1
GDRX icon
GoodRx Holdings
GDRX
+$3.34M
2
XYZ
Block Inc
XYZ
+$3.17M
3
AMD icon
Advanced Micro Devices
AMD
+$2.94M
4
AVTR icon
Avantor
AVTR
+$2.82M
5
C icon
Citigroup
C
+$2.81M

Sector Composition

Rank Sector Weight
1 Technology 54.56%
2 Consumer Discretionary 11.89%
3 Healthcare 8.7%
4 Communication Services 6.18%
5 Financials 5.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MMM icon
76
3M
MMM
$92.9B
$200K 0.15%
+1,349
New +$201K
ALLY icon
77
Ally Financial
ALLY
$13.5B
– –
-39,615
Closed -$2.02M
AVTR icon
78
Avantor
AVTR
$8.89B
– –
-68,858
Closed -$2.82M
AXP icon
79
American Express
AXP
$233B
– –
-13,123
Closed -$2.2M
BA icon
80
Boeing
BA
$186B
– –
-10,118
Closed -$2.23M
BNTX icon
81
BioNTech
BNTX
$22.6B
– –
-1,341
Closed -$366K
BURL icon
82
Burlington
BURL
$23.2B
– –
-8,327
Closed -$2.36M
C icon
83
Citigroup
C
$228B
– –
-40,045
Closed -$2.81M
CHSCO
84
CHS Inc Class B Preferred Stock
CHSCO
$551M
– –
-14,220
Closed -$406K
CRL icon
85
Charles River Laboratories
CRL
$12.5B
– –
-6,294
Closed -$2.6M
DOW icon
86
Dow Inc
DOW
$22.2B
– –
-39,415
Closed -$2.27M
DUK.PRA icon
87
Duke Energy Corp Series A Preferred Stock
DUK.PRA
$983M
– –
-19,362
Closed -$537K
DVAX
88
DELISTED
Dynavax Technologies
DVAX
– –
-12,495
Closed -$240K
GDRX icon
89
GoodRx Holdings
GDRX
$1.26B
– –
-81,372
Closed -$3.34M
GOODO
90
Gladstone Commercial Corp 6.00% Series G Preferred Stock
GOODO
$82.9M
– –
-22,320
Closed -$604K
HCA icon
91
HCA Healthcare
HCA
$88.4B
– –
-835
Closed -$203K
INN.PRF
92
Summit Hotel Properties 5.875% Series F Preferred Stock
INN.PRF
$70.2M
– –
-20,000
Closed -$523K
PEB.PRH icon
93
Pebblebrook Hotel Trust 5.700% Series H Preferred Shares
PEB.PRH
$145M
– –
-40,000
Closed -$1M
REGN icon
94
Regeneron Pharmaceuticals
REGN
$79B
– –
-4,549
Closed -$2.75M
SBUX icon
95
Starbucks
SBUX
$120B
– –
-22,633
Closed -$2.5M
SF.PRD icon
96
Stifel Financial Corp 4.50% Series D Preferred Stock
SF.PRD
$192M
– –
-20,000
Closed -$506K
T icon
97
AT&T
T
$162B
– –
-10,593
Closed -$216K
USMV icon
98
iShares MSCI USA Min Vol Factor ETF
USMV
$24B
– –
-3,433
Closed -$252K
VZ icon
99
Verizon
VZ
$194B
– –
-41,773
Closed -$2.26M
WFC.PRL icon
100
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.67B
– –
-1,638
Closed -$2.43M
1 2 3
4
5

Similar funds

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
RMCM
Reynders McVeigh Capital Management Boston, Massachusetts $1.98B AUM 23.37% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return
SC
Syon Capital San Francisco, California $1.99B AUM 22.67% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BC
Blackhill Capital Morristown, New Jersey $1.94B AUM 18.09% 1-Year Est. Return

F/M Investments's Q4 2021 Portfolio in Review

As of Q4 2021, F/M Investments held 108 positions worth $137M, down 2.2% from $140M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

F/M Investments withdrew a net $20.9M in Q4 2021, closing 31 positions and reducing 23 holdings. Its most notable exit was GoodRx Holdings, an estimated $3.34M position sold in full.

By sector, the portfolio is most concentrated in Technology at 55% of assets, up from 38% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, F/M Investments opened a new position in Qualcomm worth $3.51M.

  • F/M Investments's largest Q4 2021 buy was Qualcomm: 19,205 shares worth $3.51M.
  • F/M Investments added most to Pfizer in Q4 2021, an estimated $2.88M increase.
  • F/M Investments's biggest Q4 2021 reduction was Advanced Micro Devices, cutting an estimated $2.94M.
  • F/M Investments fully exited GoodRx Holdings in Q4 2021, selling an estimated $3.34M.
  • F/M Investments's ten largest holdings make up 52% of its $137M portfolio in Q4 2021.
  • F/M Investments opened 28 new positions and closed 31 in Q4 2021.
  • F/M Investments's portfolio value fell 2.2% quarter-over-quarter to $137M.

Based on F/M Investments's 13F filing for Q4 2021, filed 4 Feb 2022.